Variable FHIT transcripts in non-neoplastic tissues

Genes Chromosomes and Cancer

Volumn 19, Issue 4, 1997, Pages 215-219

  Panagopoulos, Ioannis ^a   Thelin, Sofia ^a   Mertens, Fredrik ^a   Mitelman, Felix ^a   Åman, Pierre ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE;

ARTICLE; CHROMOSOME 3P; CHROMOSOME BAND; CLINICAL ARTICLE; EXON; GENE DELETION; GENETIC MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0030755670     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2264(199708)19:4<215::aid-gcc2>3.0.co;2-#     Document Type: Article

References (11)

1. Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81:1991-1995.
2. Daffada AAI, Dowsett M (1995) Tissue-dependent expression of a novel splice variant of the human oestrogen receptor. J Steroid Biochem Molec Biol 55:413-421.
3. Ermak G, Jennings T, Boguniewicz A, Figge J (1996a) Novel CD44 messenger RNA isoforms in human thyroid and breast tissues feature unusual sequence rearrangements. Clinical Cancer Res 2:1251-1254.
4. Ermak G, Jennings T, Robinson L, Ross JS, Figge J (1996b) Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma. Cancer Res 56:1037-1042.
5. Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM (1996) The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56:3173-3179.
6. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
7. Panagopoulos I, Pandis N, Thelin S, Petersson C, Mertens F, Borg Å, Krisroffersson U, Mitelman F, Åman P (1996) The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res 56:4871-4875.
8. Petersson C, Pandis N, Mertens F, Adeyinka A, Ingvar C, Ringberg A, Idvall I, Bondeson L, Borg Å, Olsson H, Kristoffersson U, Mitelman F (1996) Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families. Genes Chromosom Cancer 16:185-188.
9. Sozzi G, Alder H, Tornielli S, Corletto V, Baffa R, Veronese ML, Negrini M, Pilotti S, Pierotti MA, Huebner K, Croce CM (1996a) Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res 56:2472-2474.
10. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K, Croce CM (1996b) The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85:17-26.
11. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, Croce CM (1996) FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 93:9770-9775.